MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
51.04
+4.62 (9.95%)
At close: Sep 12, 2024, 4:00 PM
51.33
+0.29 (0.57%)
After-hours: Sep 12, 2024, 6:55 PM EDT
MLTX Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 12, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 3,210 | 3,620 | 409 | - |
| Market Cap Growth | 4.94% | 784.47% | - | - |
| Enterprise Value | 2,703 | 3,189 | 353 | - |
| Last Close Price | 51.04 | 60.39 | 10.50 | 9.89 |
| PE Ratio | - | -82.39 | -6.17 | -1.20 |
| PB Ratio | 6.16 | 7.05 | 5.95 | - |
| P/FCF Ratio | -42.58 | -84.06 | -7.32 | - |
| P/OCF Ratio | -42.91 | -84.62 | -7.32 | - |
| EV/EBITDA Ratio | -28.48 | -58.93 | -5.43 | - |
| EV/EBIT Ratio | -28.46 | -58.92 | -5.43 | - |
| EV/FCF Ratio | -34.36 | -74.05 | -6.32 | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | -1.29 |
| Debt / FCF Ratio | -0.05 | -0.09 | -0.01 | -0.35 |
| Quick Ratio | 42.46 | 51.38 | 9.44 | 0.39 |
| Current Ratio | 43.71 | 51.59 | 9.98 | 0.46 |
| Return on Equity (ROE) | -11.32% | -15.14% | -225.85% | - |
| Return on Assets (ROA) | -9.32% | -11.21% | -93.99% | - |
| Return on Capital (ROIC) | -9.49% | -11.54% | -112.32% | - |
| Earnings Yield | -1.71% | -0.99% | -12.21% | - |
| FCF Yield | -2.02% | -1.19% | -13.66% | - |
| Buyback Yield / Dilution | -49.62% | -67.30% | -274.47% | - |
| Total Shareholder Return | -49.62% | -67.30% | -274.47% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.